daytraders after market lounge 21st nov, page-3

IMC

We should be getting some announcement soon regarding the NASH trials which is The global markets for treatment of these chronic diseases is estimated in the order of magnitude of
$Billions annually.

Immuron’s patent is expected to support Immuron’s competitive advantages in these markets.

There can be upside from here on a trend line, as always DYOR

Over and out today